Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Autodesk Inc (ADSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Autodesk Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Autodesk Inc trades at $248.55 (market cap $53.12B). The key difference: Autodesk Inc is far larger — about 10.5× ACADIA Pharmaceuticals Inc.'s market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Autodesk Inc nearer its low. Which is the better fit depends on your goals.
| ACAD | ADSK | |
|---|---|---|
Market Cap | $5.07B | $53.12B |
Sector | Health | Technology |
52-Week High | $29.41 | $326.79 |
52-Week Low | $20.06 | $187.72 |
Enterprise Value | $4.19B | $52.92B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Autodesk Inc
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →
